1-3 of 3
Norbert Meidenbauer
Close
Sort by
Journal Articles

Modified Risk-Stratified Sequential Treatment in B-Cell Post-Transplant Lymphoproliferative Disorder (PTLD) after Solid Organ Transplantation (SOT): The Prospective Multicenter Phase II PTLD-2 Trial

Heiner Zimmermann, Christian Koenecke, Martin H. Dreyling, Christiane Pott, Ulrich Dührsen, Dennis Hahn, Norbert Meidenbauer, Ingeborg A Hauser, Mathias J. Rummel, Dominik Wolf, Michael Heuser, Christian Schmidt, Peter Schlattmann, Matthias Ritgen, Reiner Siebert, Ilske Oschlies, Ioannis Anagnostopoulos, Ralf Ulrich Trappe
Journal: Blood
Blood (2021) 138 (Supplement 1): 3555.
https://doi.org/10.1182/blood-2021-146823
Published: 2021
Journal Articles

Inhibitory effect of tumor cell–derived lactic acid on human T cells

Karin Fischer, Petra Hoffmann, Simon Voelkl, Norbert Meidenbauer, Julia Ammer, Matthias Edinger, Eva Gottfried, Sabine Schwarz, Gregor Rothe, Sabine Hoves, Kathrin Renner, Birgit Timischl, Andreas Mackensen, Leoni Kunz-Schughart, Reinhard Andreesen, Stefan W. Krause, Marina Kreutz
Journal: Blood
Blood (2007) 109 (9): 3812–3819.
https://doi.org/10.1182/blood-2006-07-035972
Published: 2007
Includes: Supplemental data
Journal Articles

Adoptive T Cell Therapy Using Antigen-Specific CD8 + T Cells for the Treatment of Patients with Cancer: A Phase I Clinical Study.

Andreas Mackensen, MD, Norbert Meidenbauer, MD, Sandra Vogl, Monika Laumer, Reinhard Andreesen, MD
Journal: Blood
Blood (2005) 106 (11): 2393.
https://doi.org/10.1182/blood.V106.11.2393.2393
Published: 2005